AGP Picks
View all

The Georgian Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Georgian Health Digest.

Press releases published on November 6, 2026

ICU Medical to Present at the 2026 Jefferies Global Healthcare Conference in London
Quoin Pharmaceuticals’ Latest NETHERTON NOW Video Details the Life of a Family Living with Netherton Syndrome
CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026
BioCardia Completes Clinical Consultation Process with Japan's PMDA for CardiAMP Cell Therapy System, Advancing Toward Submission of Marketing Approval Application
バイオカーディア、カーディAMP細胞治療システムに関して日本のPMDAとの臨床相談手続を完了し、販売承認申請の提出に向けて進捗
OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook
CG Oncology Reports Third Quarter 2026 Financial Results and Provides Business Updates
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference
Curonix Freedom® Peripheral Nerve Stimulator (PNS) System Named Top New Pain Management Technology in Orthopedics This Week's Inaugural 2026 Awards
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results
Protara Therapeutics Announces Third Quarter 2026 Financial Results and Provides a Business Update
MIMEDX to Participate in Upcoming Investor Conferences
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Once-Weekly TransCon® CNP (Navepegritide) to Receive 10 Years of Market Exclusivity Upon Approval in the European Union
Regenerative Ophthalmology Takes Center Stage This November 7 at the Next Generation Medicine Congress 2026 in Dubai
Davion Healthcare Plc Appoints Vienna Capital Partners to Support US$100 Million Acquisition Financing Strategy
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
InflaRx Announces Publication of Phase 1 Data Demonstrating Favorable Safety and Pharmacokinetic/Pharmacodynamic Profile of Izicopan
Can-Fite to Pursue Global Licensing and Strategic Partnerships at BIO-Europe 2026 Following Recent Clinical and Intellectual Property Milestones

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Georgian Health Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.